|
Q2 FY2026
As of Jul 4, 2026
|
Q1 FY2026
As of Apr 4, 2026
|
Q4 FY2025
As of Jan 3, 2026
|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 28, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 30, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Trade receivables, net | |||||||||||||
| Inventories | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Derivative assets – current | |||||||||||||
| Total current assets | |||||||||||||
| Property and equipment, net | |||||||||||||
| Right-of-use lease assets | |||||||||||||
| Goodwill | |||||||||||||
| Intangible assets, net | |||||||||||||
| Deferred tax assets | |||||||||||||
| Other assets | |||||||||||||
| Derivative assets - non-current | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and Stockholders’ Equity: | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||
| Accrued payroll and related taxes | |||||||||||||
| Lease liabilities – current | |||||||||||||
| Current portion of long-term debt | |||||||||||||
| Total current liabilities | |||||||||||||
| Long-term debt, net | |||||||||||||
| Lease liabilities – non-current | |||||||||||||
| Derivative liabilities – non-current | |||||||||||||
| Deferred tax liabilities | |||||||||||||
| Other liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Stockholders’ equity: | |||||||||||||
| Preferred stock, $0.000001 par value, 100,000 and zero shares authorized; zero shares issued and outstanding | |||||||||||||
| Common stock, $0.000001 par value, 800,000 and 1,000,000 shares authorized; 160,453 and 141,590 shares issued and outstanding | |||||||||||||
| Preferred stock, $0.000001 par value, 100,000 shares authorized; zero shares issued and outstanding | |||||||||||||
| Common stock, $0.000001 par value, 800,000 shares authorized; 153,769 and 155,283 shares issued and outstanding | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Accumulated other comprehensive income | |||||||||||||
| Total stockholders’ equity | |||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
